Genetic & rare diseases, Cellular & molecular biology, Corporate, Product

Video: European customers share their success stories

At ESHG in Vienna, Illumina representatives engaged with an impressive group of geneticists and entrepreneurs

European customers share their success stories
June 14, 2022

Illumina teams proudly joined the 55th European Society of Human Genetics (ESHG) meeting in Vienna to support the research community in overcoming challenges in genomics and unlocking the power of the genome. A premier human genetics conference in Europe, attracting more than 3,500 delegates this year, ESHG promotes advancements in genetic research, drawing leading researchers, clinicians, academics, and pharmaceutical and biotechnology companies to forge new collaborations and foster education.

At ESHG, Illumina team members spoke with several customers to learn more about their genomic breakthroughs and vision for the future, particularly in the field of rare genetic diseases.

Customers are at the center of everything we do. The ESHG gives us a fabulous opportunity to listen to them and understand their needs, enabling transformational change in research and, ultimately, human health.

Recent Articles

Trailblazing study shows early CGP leads to better precision treatments
Trailblazing study shows early CGP leads to better precision treatments
How two systems integration scientists ensure a smooth workflow on MiSeq i100
How two systems integration scientists ensure a smooth workflow on MiSeq i100
Single-cell RNA analysis finds possible genetic drivers of bone cancer
Single-cell RNA analysis finds possible genetic drivers of bone cancer